Abstract
Haemophilus influenzae is a human-restricted pathogen that colonises the nose and throat and to a lesser extent the conjunctivae and genital tract.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Further Reading
Anderson EC, Begg NT, Crawshaw SC, Hargreaves RM, Howard AJ, Slack MP. Epidemiology of invasive Haemophilus influenzae infections in England and Wales in the pre-vaccination era (1990-2). Epidemiol Infect. 1995;115(1):89–100.
Collins S, Ramsay M, Campbell H, Slack MP, Ladhani SN. Invasive Haemophilus influenzae type b disease in England and Wales: who is at risk after 2 decades of routine childhood vaccination? Clin Infect Dis. 2013;57(12):1715–21.
Daum RS, Zenko CE, Given GZ, et al. Magnitude of interference after diphtheria-tetanus toxoid-acellular pertussis/Haemophilus influenzae type b capsular polysaccharide vaccination is related to the number of doses administered. J Infect Dis. 2001;184:1293–9.
Dagan R, Poolman JT, Zepp F. Combination vaccines containing DTPaHib: impact of IPV and co-administration of CRM197 conjugates. Expert Rev Vaccines. 2008;7:97–115.
Decker MD, Edwards KM, Bradley R, Palmer P. Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines. J Pediatr. 1992;120(2 pt. 1):184–9.
European Centre for Disease Prevention and Control. Annual epidemiological report: invasive Haemophilus influenzae. Stockholm ECDC. 2016. Available at: http://ecdc.europa.eu/en/healthtopics/Haemophilus_Influenzae_Infection/Pages/Annual-epidemiological-report-2016.aspx
Käyhty H, Peltola H, Karanko V, Makela PH. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis. 1983;147:1100.
Käyhty H, Eskola J, Peltola H, et al. Antibody responses to four Haemophilus influenzae type b conjugate vaccines. Arch Dis Child. 1991;145(2):223–7.
Kelly DF, Moxon ER, Pollard AJ. Haemophilus influenzae type b conjugate vaccines. Immunology. 2004;113:163–74.
Ladhani S, Ramsay ME, Chandra M, Slack MP. EU-IBIS No evidence for Haemophilus influenzae serotype replacement in Europe after introduction of the Hib conjugate vaccine. Lancet Infect Dis. 2008;8(5):275–6.
Ladhani S, Slack MP, Heath PT, von Gottberg A, Chandra M, Ramsay ME. Invasive Haemophilus influenzae disease, Europe, 1996–2006. European Union invasive bacterial infection surveillance participants. Emerg Infect Dis. 2010a;16(3):455–63.
Ladhani S, Heath PT, Slack MP, McIntyre PB, Diez-Domingo J, Campos J, Dagan R, Ramsay ME, Participants of the European Union Invasive Bacterial Infections Surveillance Network. Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes. Clin Microbiol Infect. 2010b;16(7):948–54.
Ladhani SN, Ladhani SN, Collins S, Vickers A, Litt DJ, Crawford C, Ramsay ME, Slack MPE. Invasive Haemophilus influenzae serotype e and f disease in England and Wales. Emerg Infect Dis. 2012;18(5):725–32.
McVernon J, Howard AJ, Slack MP, Ramsay ME. Long-term impact of vaccination on Haemophilus influenzae type b (Hib) carriage in the United Kingdom. Epidemiol Infect. 2004;132:765–7.
Pace D. Glycoconjugate vaccines. Expert Opin Biol Ther. 2013;13(1):11–33.
Paul Erhlich Institute. Vaccines for Haemophilus influenzae type b. n.d.. Available at: http://www.pei.de/EN/medicinal-products/vaccines-human/haemophilus-influenzae-type-b-hib/haemophilus-influenzae-type-b-hib-node.html
Peltola H, Käyhty H, Sivonen A, Mäkelä H. Haemophilus influenzae type b capsular polysaccharide vaccine in children : a double blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland. Pediatrics. 1977;60:730–7.
Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev. 2000;13:302–17.
Poolman J, Kaufhold A, DeGrave D, Goldblatt D. Clinical relevance of lower Hib response in DTPa-based combination vaccines. Vaccine. 2001;19:2280–5.
Slack MPE, Azzopardi HJ, Hargreaves RM, Ramsay ME. Enhanced surveillance of invasive Haemophilus influenzae disease in England, 1990 to 1996: impact of conjugate vaccine. Pediatr Infect Dis J. 1998;17:S204–7.
Sturgess AW, Rush K, Charbonneau RJ, et al. Haemophilus influenzae type b conjugate vaccine stability: catalytic depolymerisation of PRP in the presence of aluminium hydroxide. Vaccine. 1999;17:1169–78.
Takala A, Eskola J, Peltola H, Makela H. Epidemiology of invasive Haemophilus influenzae type b disease among children in Finland before vaccination with Haemophilus influenzae type b conjugate vaccine. Ped Infect Dis J. 1989;8:297–301.
Takala AK, Meuman O, Kleemola M, et al. Preceding respiratory infection predisposing for primary and secondary invasive Haemophilus influenzae type b disease. Ped Infect Dis J. 1993;12:189–95.
Van Eldere J, Slack M, Ladhani S, Cripps A. Non-typeable Haemophilus influenzae: an under-recognised pathogen. Lancet Infect Dis. 2014;14(12):1281–92.
Vidor E, Offenbach A, Fletcher MA. Haemophilus influenzae type b vaccine: reconstitution of lyophilised PRP-T vaccine with a pertussis- containing paediatric combination vaccine, or a change in the primary series immunisation schedule, may modify the serum anti-PRP antibody responses. Cur Med Res Open. 2001;17:197–209.
Watt JP, Wolfson LJ, O’Brien KL. Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates. Lancet. 2009;374:903–11.
World Health Organisation. Third dose of Hib vaccine Reported estimates 2016. Available at: http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tscoveragehib3.html
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Slack, M.P.E. (2017). Haemophilus influenzae type b (Hib) Vaccines. In: Vesikari, T., Van Damme, P. (eds) Pediatric Vaccines and Vaccinations. Springer, Cham. https://doi.org/10.1007/978-3-319-59952-6_19
Download citation
DOI: https://doi.org/10.1007/978-3-319-59952-6_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-59950-2
Online ISBN: 978-3-319-59952-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)